Skip to main content
SpringerLink
Log in

Prospective evaluation of fluorine-18 fluorodeoxyclucose positron emission tomography in breast cancer for staging of the axilla related to surgery and immunocytochemistry

  • Original Article
  • Published:
European Journal of Nuclear Medicine Aims and scope Submit manuscript

Abstract

The noninvasive staging of axillary lymph nodes for metastases is investigated in patients with breast cancer prior to surgery by positron emission tomography (PET) with fluorine- l8-fluoro-2-deoxy-d-glucose (18F-FDG). In 124 patients with newly diagnosed breast cancer, whole-body PET was performed to determine the average differential uptake ratio (DUR) of18F-FDG in the axillary lymph nodes. Results were correlated with the number of the dissected lymph nodes, size of the primary tumor, tumor type, tumor grade, estrogen and progesterone receptors, DNA ploidy, and the proportion of cells in the synthetic phase of the cell cycle (S-phase). In this prospective study of 124 patients with breast carcinoma, PET correctly categorized all 44 tumor-positive axillary lymph nodes, a sensitivity of 100%. Sixty tumor-negative axillary lymph nodes were negative by PET and 20 tumor-negative axillary lymph nodes were positive by PET. No false-negative PET findings were encountered. A weak correlation was found between DUR and tumor size as well as between DUR and the S-phase of the tumor. In patients with breast carcinoma,18F-FDG PET can be of value in evaluating axillary lymph nodes for metastatic involvement prior to surgery. It is of particular importance that no false-negative PET findings were encountered, and axillary lymph node dissection might not be necessary in patients without axillary uptake by PET. The DUR of the positive axillary lymph nodes seems to bear a relationship with some of the purported prognostic parameters of the primary tumor.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Boring CC, Suires TS, Tong T. Cancer Statistics 1993.CA Cancer J Clin 1993; 43: 7–26.

    Google Scholar 

  2. Berg JW, Hutter RVP. Breast cancer.Cancer 1995; 75: 257–269.

    Google Scholar 

  3. Ries LAG, Miller BA, Hankey BF, Kosary CL, Harras A, Edwards BK. Cancer statistics review 1973-91: tables and graphs.National Institutes of Health Publication no. 94-2798, Bethesda, Md: National Cancer Institute, 1994.

    Google Scholar 

  4. Anderson I, Aspegren K, Janzon I, Landberg T, Lindholm K, Linell F, Ljungberg O, Ranstam J, Sigfusson B. Mammographic screening and mortality from breast cancer: the Malmo mammographic screening trial.Br Med J 1988; 297: 943–948.

    Google Scholar 

  5. Warburg O.The metabolism of tumors. London; Constable; 1938; 254–270.

    Google Scholar 

  6. Brownell G, Sweet H. Localization of brain tumors with positron emitters.Nucleonics 1953; 11: 40–45.

    Google Scholar 

  7. Di Chiro G, DeLaPaz RL, Brooks RA, Sokoloff L, Kornblith PL, Smith BH, Patronas NJ, Kufta CV, Kessler RM, Johnston GS, Manning RG, Wolf AP. Glucose utilization of cerebral gliomas measured by (18)fluorodeoxyglucose and positron emission tomography.Neurology 1982; 32: 1323–1329.

    Google Scholar 

  8. Strauss LG, Clorius JH, Schlag P, Lehner B, Kimmig B, Engenhart R, Marin-Grez M, Helus F, Oberdorfer F, Schmidlin P, van Kaick G. Recurrence of colorectal tumors: PET evaluation.Radiology 1989; 170: 329–332.

    Google Scholar 

  9. Wahl RL, Cody RL, Hutchins GD, Mudgett EE. Primary and metastatic breast carcinoma: initial clinical evaluation with PET with the radiolabeled glucose analogue 2-F-18-fluoro-2deoxy-d-glucose.Radiology 1991; 179: 765–770.

    Google Scholar 

  10. Tse NY, Hoh CK, Hawkins RA, Zinner MJ, Dahlbom M, Choi Y, Maddahi J, Brunicardi FC, Phelps ME, Glaspy JA. The application of positron emission tomographic imaging with fluorodeoxyglucose to the evaluation of breast disease.Ann Surg 1992; 216: 27–34.

    Google Scholar 

  11. Nieweg OE, Kim EE, Wong WH, Broussard WF, Singletary SE, Hortobagyi GN, Tilbury RS. Positron emission tomography with fluorine- 18-deoxyglucose in the detection and staging of breast cancer.Cancer 1993; 71: 3920–3925.

    Google Scholar 

  12. Nieweg OE, Wong WH, Singletary SE, Hortobagyi GN, Kim EE. Positron emission tomography of glucose metabolism in breast cancer.Ann NY Acad Sci 1993; 698: 423–428.

    Google Scholar 

  13. Adler LP, Crowe JP, Al-Kaisi NK, Sunshine JL. Evaluation of breast masses and axillary lymph nodes with [F-18] 2-deoxy2-fluoro-d-glucose PET.Radiology 1993; 187: 743–750.

    Google Scholar 

  14. Minn H, Zasadny KR, Quint LE, Wahl RL. Lung cancer: reproducibility of quantitative measurement for evaluating 2F18-fluoro-2-deoxy-d-glucose uptake at PET.Radiology 1995; 196: 167–173.

    Google Scholar 

  15. Inokuma T, Tamaki N, Torizuka T, Fujita T, Magata Y, Yonekura Y, Ohshio G, Imamura M, Konishi J. Value of fluorine18-fluorodeoxyglucose and thallium-201 in the detection of pancreatic cancer.J Nucl Med 1995; 36: 229–235.

    Google Scholar 

  16. Braams JW, Pruim J, Freling NJM, Nikkels PGJ, Rodenburg JLN, Boering G, Vaalburg W, Vermey A. Detection of lymph node metastases of the head and neck with FDG-PET and MRI.J Nucl Med 1995; 36: 211–216.

    Google Scholar 

  17. Gupta N, Chandramouli B, Reeb S, Dewan N. Diagnostic evaluation of solitary pulmonary nodules (SPNs) using PET-FDG imaging.J Nucl Med 1994; 35 Suppl 5: 76.

    Google Scholar 

  18. Grabbe E, Winkler R. Local recurrence after sphincter-saving resection for rectal and rectosigmoid carcinoma: value of various diagnostic methods.Radiology 1995; 155: 305–310.

    Google Scholar 

  19. Holle LH, Trampert L, Lung-Kurt S, Villena-Heinsen CE, Püschel W, Schmidt S, Oberhausen E. Investigation of breast tumors with fluorine-l8-fluorodeoxyglucose and SPECT.J Nucl Med 1996; 37: 615–622.

    Google Scholar 

  20. Hermanek P, Henson DE, Hutter RVP, eds.UICC complement the 4th edition of the TNM classification of malignant tumors. TNM supplement 1993: a commentary on uniform use. Berlin Heidelberg New York: Springer, 1993.

    Google Scholar 

  21. Lindholm P, Minn H, Leskinen-Kallio S, Bergman J, Ruotsalainen U, Joensuu H. Influence of the blood glucose concentration on FDG uptake in cancer — a PET study.J Nucl Med 1993; 34: 1–6.

    Google Scholar 

  22. Zasadny KR, Wahl RL. Standardized uptake values of normal tissues at PET with 2-fluorine-18-fluoro-2-deoxy-d-glucose: variations with body weight and method for correction.Radiology 1993; 189: 874–850.

    Google Scholar 

  23. Hoh CK, Hawkins RA, Glaspy JA, Dahlbom M, Tse NY, Hoffman EJ, Schiepers C, Choi Y, Rege S, Nitsche E, Phelps ME. Cancer detection with whole-body PET using 2-18-F-fluoro-2-deoxy-d-glucose.J Comput Assist Tomogr 1993; 17: 582–589.

    Google Scholar 

  24. Sigurdsson H, Baldetorp B, Borg A, Dalberg M, Fernö M, Killander D, Olsson H. Indicators of prognosis in node-negative breast cancer.N Engl J Med 1990; 322: 1045–1053.

    Google Scholar 

  25. McGuire WL, Clark GM. Prognostic factors and treatment decisions in axillary node-negative breast cancer.N Engl J Med 1992; 326: 1756–1761.

    Google Scholar 

  26. Clark GM, Wenger CR, Beardslee BA, Owens MA, Pounds G, Oldaker T, Vendely P, Pandian MR, Harrington D, McGuire WL. How to integrate steroid hormone receptor, flow cytometry, and other prognostic information in regard to primary breast cancer.Cancer 1993; 71: 2157–2162.

    Google Scholar 

  27. Noguchi S, Aihara T, Nakamori S, Motomura K, Inaji H, Imaoka S, Koyama H. The detection of breast carcinoma micrometastases in axillary lymph nodes by means of reverse tran scriptase-polymerase chain reaction.Cancer 1994; 74: 1595–1600.

    Google Scholar 

  28. Rosen PP, Lesser ML, Kinne DW, Beattie EJ. Discontinuous or “skip” metastases in breast carcinoma: analysis of 1228 axillary dissections.Ann Surg 1982; 197: 276–283.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University of Illinois College of Medicine at Peoria, USA

    Christa I. Utech & Peter F. Winter

  2. Downstate Clinical PET Center at Methodist Medical Center of Illinois, Peoria, Illinois, USA

    Carter S. Young

Authors
  1. Christa I. Utech
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Carter S. Young
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Peter F. Winter
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Utech, C.I., Young, C.S. & Winter, P.F. Prospective evaluation of fluorine-18 fluorodeoxyclucose positron emission tomography in breast cancer for staging of the axilla related to surgery and immunocytochemistry. Eur J Nucl Med 23, 1588–1593 (1996). https://doi.org/10.1007/BF01249621

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01249621

Key words

Search

Navigation